Innovative drug discovery solutions for infections

In this article, biotechnology company Creative Biolabs highlights its drug discovery solutions and microbiology reagents, asserting that it is well-equipped to help global researchers address the critical issue of infections.

Pathogens, the culprit of most infections, pose a significant threat to global health, and the development of effective therapies and prevention methods is a pressing concern. Creative Biolabs, a biotechnology company, supports new drug development against infectious diseases, providing services and varying products to help researchers and pharmaceutical companies tackle this critical health issue.

Antibacterial Drug Discovery

Creative Biolabs' expertise includes antibacterial drug discovery to cover the entire drug development process, from target identification and validation to hit discovery, lead optimization, and IND enabling, helping clients to develop effective antibacterial drugs against various bacterial infections, which exert functions via diverse modes of action such as inhibitors of cell wall biosynthesis, protein biosynthesis, membrane function, nucleic acid synthesis, metabolic pathways, and ATP synthase.

"Our capabilities even cover severe bacterial pathogens, such as Acinetobacter baumannii, Helicobacter pylori, and Shigella." According to a scientist at Creative Biolabs.

Antifungal Drug Discovery

Creative Biolabs also offers antifungal drug discovery services. The initiative is particularly important in light of the growing threat of fungal resistance, which highlights the need for new and effective antifungal treatments against aspergillosis, blastomycosis, candidiasis, and more.

Microbiology Reagents

Creative Biolabs' commitment to advancing infectious disease research extends beyond drug discovery. They also offer comprehensive microbiology reagents, including MIB-CM Dry Powder Medium and MIB-CM Chromogenic Medium, which are designed to facilitate the study of microorganisms in a fast product transportation and short cycle, enabling scientists to better understand the mechanisms of infection and develop effective countermeasures.

"We have established ourselves as a trusted partner for researchers and pharmaceutical companies, with years of experience dealing with infections. Our team has developed a deep understanding of the complexities of infectious diseases and the challenges of drug discovery. This expertise, combined with cutting-edge technologies and a commitment to quality, makes us the ideal partner for anyone looking to develop effective treatments against infectious diseases," the scientist added.


Recent Issues